ISOLATION AND IDENTIFICATION OF 4-KETOCYCLOPHOSPHAMIDE, A POSSIBLE ACTIVE FORM OF ANTITUMOR AGENT CYCLOPHOSPHAMIDE

[1] ARNOLD H, 1961, ARZNEIMITTEL-FORSCH, V11, P143

[2] BROCK N, 1963, ARZNEIMITTEL-FORSCH, V13, P1021

[3] COHEN JL, 1969, P AM ASSOC CANC RES, V10, P14

[4] FRIEDMAN ORRIE M., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA, V51, P327

[5] HAGGARD MARY E., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA, V51, P403

[6] NISSENMEYER R, 1960, CANC CHEMOTHER REP, V9, P51

[7] RAUEN HM, 1967, ARZNEI-FORSCHUNG, V17, P599

[8] DIE BIOLOGISCHE AKTIVIERUNG VON ENDOXAN [J]. NATURWISSENSCHAFTEN, 1965, 52 (16) : 477 - &

[9] SULLIVAN MARGARET P., 1967, CANCER CHEMOTHER REP, V51, P393

[10] SUTOW W. W., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA NEW ORLEANS LA JANUARY 25 1966, V51, P407

[1] ARNOLD H, 1961, ARZNEIMITTEL-FORSCH, V11, P143

[2] BROCK N, 1963, ARZNEIMITTEL-FORSCH, V13, P1021

[3] COHEN JL, 1969, P AM ASSOC CANC RES, V10, P14

[4] FRIEDMAN ORRIE M., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA, V51, P327

[5] HAGGARD MARY E., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA, V51, P403

[6] NISSENMEYER R, 1960, CANC CHEMOTHER REP, V9, P51

[7] RAUEN HM, 1967, ARZNEI-FORSCHUNG, V17, P599

[8] DIE BIOLOGISCHE AKTIVIERUNG VON ENDOXAN [J]. NATURWISSENSCHAFTEN, 1965, 52 (16) : 477 - &

[9] SULLIVAN MARGARET P., 1967, CANCER CHEMOTHER REP, V51, P393

[10] SUTOW W. W., 1967, CANCER CHEMOTHER REPSYMPOSIUM ON CYCLOPHOSPHAMIDE IN PEDIATRIC NEOPLASIA NEW ORLEANS LA JANUARY 25 1966, V51, P407